Hydrogen-Rich Saline Protects Against Liver Damage in Mice Study
- Authors
- Hanyong Sun, Lei Chen, WeiPing Zhou, Liang Hu, Liang Li, QianQian Tu, YanXin Chang, Qu Liu, XueJun Sun, MengChao Wu, HongYang Wang
- Journal
- Journal of Hepatology
- Year
- 2011
- DOI
- 10.1016/j.jhep.2010.08.011
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Acute Liver Injury
- Body System
- Hepatic
TL;DR
Hydrogen-rich saline can protect the liver from damage by neutralizing harmful oxygen-related molecules without interfering with normal cell processes.
Key Finding
Hydrogen-rich saline significantly reduced liver damage, cirrhosis development, and abnormal cell proliferation in mice by neutralizing harmful reactive oxygen species while preserving beneficial cellular signaling.
Summary
Researchers tested hydrogen-rich saline (a salt water solution containing hydrogen gas) in mice with experimentally induced liver damage. They found that hydrogen-rich saline reduced harmful molecules called reactive oxygen species in liver tissue, decreased liver injury and scarring, and slowed abnormal cell growth—all by activating protective cellular pathways.
Practical Takeaway
This mouse study suggests hydrogen-rich saline may have potential as a liver-protective treatment, but these results cannot yet be applied to humans. Much more research, including human clinical trials, would be needed before any health claims could be made. The study's findings are promising but preliminary.
Abstract
Reactive oxygen species (ROS) are considered to play a prominent causative role in the development of various hepatic disorders. Antioxidants have been effectively demonstrated to protect against hepatic damage. Hydrogen (H(2)), a new antioxidant, was reported to selectively reduce the strongest oxidants, such as hydroxyl radicals (·OH) and peroxynitrite (ONOO(-)), without disturbing metabolic oxidation-reduction reactions or disrupting ROS involved in cell signaling. In place of H(2) gas, hydrogen-rich saline (HS) may be more suitable for clinical application. We herein aim to verify its protective effects in experimental models of liver injury. H(2) concentration in vivo was detected by hydrogen microelectrode for the first time. Liver damage, ROS accumulation, cytokine levels, and apoptotic protein expression were, respectively, evaluated after GalN/LPS, CCl(4), and DEN challenge. Simultaneously, CCl(4)-induced hepatic cirrhosis and DEN-induced hepatocyte proliferation were measured. HS significantly increased hydrogen concentration in liver and kidney tissues. As a result, acute liver injury, hepatic cirrhosis, and hepatocyte proliferation were reduced through the quenching of detrimental ROS. Activity of pro-apoptotic players, such as JNK and caspase-3, were also inhibited. HS could protect against liver injury and also inhibit the processes leading to liver cirrhosis and hepatocyte compensatory proliferation.